However, in agreement with our data in melanoma, FBXO32 was also shown to favor breast cancer cell xenograft development [29] and analysis of all the TCGA cohorts showed that high levels of FBXO32 were associated with bad prognosis in mesothelioma, kidney renal papillary cell carcinoma, pancreatic adenocarcinoma, and brain lower grade glioma (not shown). Here, FBXO32 is linked to breast carcinoma.